trial · primary record
ARD001
Hemophilia A
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2027-03 |
| Primary endpoint | Phase 1: Number of Participants With Treatment-Emergent Adverse Events, Serious Adverse Events, and Adverse Events of Special Interest |
| Registry ID | NCT07787091 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:49.330Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07787091
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.